Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Sales | 22,920 | 21,684 | 20,251 | 19,781 | 17,086 |
| Cost of Goods | 8,310 | 8,594 | 8,520 | 7,504 | 7,212 |
| Gross Profit | 14,610 | 13,090 | 12,260 | 12,277 | 9,874 |
| Operating Expenses | 11,464 | 11,302 | 24,620 | 10,798 | 10,674 |
| Operating Income | 3,456 | 2,382 | -12,369 | 1,983 | -588 |
| Interest Expense | 0 | 0 | 350 | 0 | 320 |
| Other Income | -265 | -140 | 849 | -159 | 1,181 |
| Pre-tax Income | 3,191 | 2,242 | -11,870 | 1,824 | 273 |
| Income Tax | 429 | 246 | -200 | 80 | 161 |
| Net Income Continuous | 2,762 | 1,996 | -11,776 | 1,744 | 112 |
| Net Income Discontinuous | N/A | N/A | -470 | N/A | N/A |
| Net Income | $2,762 | $1,996 | $-12,246 | $1,744 | $112 |
| EPS Basic Total Ops | 0.06 | 0.04 | -0.35 | 0.04 | -0.01 |
| EPS Basic Continuous Ops | 0.07 | 0.05 | -0.32 | 0.04 | -0.01 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | N/A | N/A |
| EPS Diluted Total Ops | 0.05 | 0.04 | -0.35 | 0.04 | -0.01 |
| EPS Diluted Continuous Ops | 0.06 | 0.05 | -0.32 | 0.04 | -0.01 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.01 | N/A | N/A |
| EBITDA(a) | $4,880 | $3,813 | $-10,887 | $3,407 | $774 |